The risk of comorbidities, including T2DM, cardiovascular disease, dyslipidemia, and atherosclerosis, is independently correlated with visceral fat mass that is inadequately distinguished by BMI or total body fat
Biochimica et Biophysica Acta, 1334 , 200206
Q15: Why did Melanotan 2 development stop while PT-141 and afamelanotide moved forward
People with severe kidney disease (eGFR below 30) People with serious liver disease Before surgery or contrast dye procedures doctor will temporarily stop it References: Metformin StatPearls, NIH Bookshelf Metformin: Update on Mechanisms of Action Nature Reviews Endocrinology Metformin Action in the GI Tract Frontiers in Pharmacology 2024 GLP-1 Receptor Agonists Ozempic, Trulicity, Victoza Explained You may have seen Ozempic trending on social media recently celebrities using it for weight loss, news articles calling it a miracle drug. But what exactly is it
Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes